We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MDVCF market cap is 0. The company's latest EPS is JPY and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 4.03B | 4.58B | 5.67B | 6.1B | 6.42B |
| Operating Income | 790.82M | 1.08B | 1.59B | 1.38B | 1.58B |
| Net Income | 554.32M | 700.22M | 1.09B | 870.51M | 979.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 4.95B | 5.32B | 5.53B | 4.9B | 6.22B |
| Total Liabilities | 924.58M | 1.18B | 1.33B | 1.29B | 1.9B |
| Total Equity | 4.02B | 4.14B | 4.21B | 3.61B | 4.32B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 1.2B | 964.36M | 1.08B | 910.8M | 1.62B |
| Investing | -31.27M | -142.58M | -26.93M | -868.75M | -437.83M |
| Financing | 199.35M | -589.64M | -1.03B | -979.36M | -225.27M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 40.03M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Medical Data Vision Company Ltd (GM) |
| Address |
10f, sumitomo fudosan kanda bldg chiyoda, tokyo 101-0053 |
| Website | https://www.mdv.co.jp |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
